Decision Curve Analysis examines the probability level at which a decision-maker would favor intervention over no intervention. At each threshold probability, it calculates net benefit by rewarding correctly identified cases and accounting for unnecessary interventions. This shows whether model-guided decisions are useful across a range of risk tolerances, rather than at only one cutoff.
Treating everyone and treating no one provide reference strategies for judging whether a prediction model adds practical value. A model is useful when its net benefit exceeds the relevant alternative across a clinically meaningful threshold range. These comparisons indicate whether using model predictions improves decisions beyond adopting a uniform intervention policy.
Discrimination and calibration describe important statistical properties of prediction models, but they do not by themselves show whether predictions improve decisions. Decision Curve Analysis adds a decision-focused perspective by weighing correctly identified cases against unnecessary interventions at selected thresholds. Consequently, a model with favorable conventional measures may not offer useful net benefit in the risk range that matters.
A typical analysis identifies clinically relevant threshold probabilities, evaluates the model at those thresholds, and calculates net benefit for each point. The results are then compared with treating everyone and treating no one. Examining the resulting patterns across the threshold range helps determine where model-based decisions provide greater practical value than the alternatives.
When several models are available, Decision Curve Analysis can compare their net benefits across the same threshold probabilities. The preferred model is not necessarily the one with the strongest discrimination or calibration alone; it is the one that offers greater decision benefit within the risk range relevant to the intended use. This supports model selection based on practical consequences.
The results can show whether applying a prediction tool improves treatment decisions for particular risk thresholds. A clinician or researcher can focus on the range in which intervention becomes worthwhile and assess whether model-guided choices outperform treating everyone or no one. This links statistical evaluation with risk-based planning and clarifies where the tool has practical relevance.